Related Experiment Videos
Prescribing guidelines for ENT medications during pregnancy
Bryan T Ambro1, Sara C Scheid, Edmund A Pribitkin
1Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, USA.
Ear, Nose, & Throat Journal
|September 25, 2003
Summary
Pregnancy alters how the body uses medications, with most drugs crossing to the fetus. Otolaryngologists must know safe prescribing practices for pregnant patients to ensure maternal and fetal well-being.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Otolaryngology
Background:
- Physiological changes during pregnancy significantly impact drug pharmacodynamics.
- Approximately 85% of pregnant women use at least one prescription medication.
- Maternal medications frequently cross the placenta, reaching significant fetal concentrations.
Purpose of the Study:
- To review the safety and efficacy of common otolaryngologic medications in pregnancy.
- To guide otolaryngologists in prescribing for gravid patients.
- To prevent adverse fetal outcomes from medication use.
Main Methods:
- Review of existing literature on drug safety in pregnancy.
- Analysis of pharmacodynamic alterations during gestation.
- Evaluation of commonly prescribed otolaryngologic drugs.
Main Results:
- Most drugs administered to pregnant individuals cross the placenta.
- Fetal drug levels can approximate maternal serum concentrations.
- Specific drug classes have varying safety profiles in pregnancy.
Conclusions:
- Otolaryngologists must be knowledgeable about medication safety in pregnant patients.
- Careful drug selection is crucial to protect both mother and fetus.
- Avoiding unnecessary prescriptions minimizes potential risks.